BeStock  
Stocks › Biotechnology › ORKA

Oruka Therapeutics ORKA

US equityMarket cap rank #1788Biotechnology
$95.81 −$1.76 (-1.80%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $95.81 0.00%
Open$95.86
Prev close$97.57
Day range$93.30 – $97.24
Volume1.98M
Market cap$6.50B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$148.44+54.9% vs. price
  • Buy 100%
Low $105.00Now $95.81Avg $148.44High $180.00

Recent rating changes

The last 20 actions on file set price targets from $105.00 to $180.00, averaging $148.68.

DateFirmRatingTarget
10 Nov 2026 UBS BUY $130.00
10 Nov 2026 Piper Sandler BUY $180.00
10 Nov 2026 Stifel BUY $150.00
10 Nov 2026 H.C. Wainwright BUY $120.00
10 Nov 2026 Barclays BUY $160.00
9 Nov 2026 BTIG BUY $151.00
27 Oct 2026 Wedbush BUY $165.00
27 Oct 2026 Leerink Partners BUY –
27 Oct 2026 H.C. Wainwright BUY $120.00
27 Oct 2026 Barclays BUY $160.00
26 Oct 2026 BTIG BUY $151.00
26 Oct 2026 Clear Street BUY $105.00
18 Oct 2026 BTIG BUY $151.00
7 Oct 2026 Piper Sandler BUY $180.00
1 Oct 2026 BTIG BUY $151.00
24 Sep 2026 Wedbush BUY $165.00
24 Sep 2026 H.C. Wainwright BUY $120.00
23 Sep 2026 LifeSci Capital BUY $175.00
23 Sep 2026 Clear Street BUY $131.00
21 Sep 2026 Barclays BUY $160.00

Discussion

No comments yet — be the first to weigh in on ORKA.

Sign in to join the discussion.

Scroll to Top